Cargando…

Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3

Detalles Bibliográficos
Autores principales:	Ogdie, Alexis, Troxel, Andrea B., Mehta, Nehal N., Gelfand, Joel M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538986/ https://www.ncbi.nlm.nih.gov/pubmed/26269404 http://dx.doi.org/10.1038/jid.2015.218

Ejemplares similares

Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom
por: Langan, Sinéad M., et al.
Publicado: (2011)

High density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction
por: Mehta, Nehal N., et al.
Publicado: (2014)

Endothelial Cell‐, Platelet‐, and Monocyte/Macrophage‐Derived Microparticles are Elevated in Psoriasis Beyond Cardiometabolic Risk Factors
por: Takeshita, Junko, et al.
Publicado: (2014)

Potential Immunological Links Between Psoriasis and Cardiovascular Disease
por: Sajja, Aparna P., et al.
Publicado: (2018)

Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk
por: KLEYN, C. Elise, et al.
Publicado: (2020)

Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study
por: Tillett, William, et al.
Publicado: (2023)

Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians
por: BERNA-RICO, Emilio, et al.
Publicado: (2023)

Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
por: Teklu, Meron, et al.
Publicado: (2021)

Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis (EDSAP): protocol for an observational, single-centre, prospective cohort study
por: Abbad-Jaime de Aragón, Carlota, et al.
Publicado: (2023)

Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting
por: Jafri, Kashif, et al.
Publicado: (2015)

Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study
por: Wan, Joy, et al.
Publicado: (2013)

Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis
por: Mehta, Nehal N, et al.
Publicado: (2013)

Viewing Psoriasis as a Systemic Disease for Better Health Outcomes
por: Gondo, George C., et al.
Publicado: (2021)

Introducing the Cardiovascular, metabolic and lipoprotein translation section of journal of translational medicine
por: Mehta, Nehal N
Publicado: (2012)

Shared genetic risk factors and causal association between psoriasis and coronary artery disease
por: Patrick, Matthew T., et al.
Publicado: (2022)

Comorbidities and cardiovascular risk factors in patients with psoriasis
por: Baeta, Isabela Guimarães Ribeiro, et al.
Publicado: (2014)

Psoriasis and Cardiovascular Risk: A Comprehensive Review
por: Masson, Walter, et al.
Publicado: (2020)

Biologics for Reducing Cardiovascular Risk in Psoriasis Patients
por: Terui, Hitoshi, et al.
Publicado: (2023)

The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
por: Abrouk, Michael, et al.
Publicado: (2016)

Strength in Numbers
Publicado: (1966)

Strength in numbers
Publicado: (2020)

Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
por: Syed, Maha N., et al.
Publicado: (2021)

CARDIOVASCULAR COMORBIDITIY IN PSORIASIS
por: Singh, Gurcharan, et al.
Publicado: (2011)

Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey
por: Armstrong, April W., et al.
Publicado: (2023)

Associations between cardiovascular risk factors and psoriasis in Iran
por: Farshchian, Mahmoud, et al.
Publicado: (2015)

The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
por: Syed, Maha N., et al.
Publicado: (2020)

Association between the systemic treatment of psoriasis and cardiovascular risk
por: Shi, Li-Qing, et al.
Publicado: (2021)

Dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous changes in a patient with psoriasis treated with adalimumab
por: Belyaeva, Elizaveta A., et al.
Publicado: (2015)

The Association between Psoriasis Area and Severity Index and Cardiovascular Risk Factor in Korean Psoriasis Patients
por: Ku, Sang Hyeon, et al.
Publicado: (2016)

Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis
por: NÄSLUND-KOCH, Charlotte, et al.
Publicado: (2022)

The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
por: Wan, Marilyn T., et al.
Publicado: (2020)

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
por: Connelly, Margery A., et al.
Publicado: (2017)

The relationship between systemic inflammation and increased left ventricular mass is partly mediated by noncalcified coronary artery disease burden in psoriasis
por: Zhou, Wunan, et al.
Publicado: (2021)

Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis
por: Nedoszytko, Bogusław, et al.
Publicado: (2020)

Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Association Among Noncalcified Coronary Burden, Fractional Flow Reserve, and Myocardial Injury in Psoriasis
por: Zhou, Wunan, et al.
Publicado: (2020)

Cardiovascular Risk in Psoriasis Patients: Clinical, Functional and Morphological Parameters
por: de Oliveira, Angélica Navarro, et al.
Publicado: (2019)

Cardiovascular findings in patients with psoriasis
por: Öztürkcan, Serap, et al.
Publicado: (2006)

Cardiovascular comorbidities in psoriasis (Review)
por: Branisteanu, Daciana Elena, et al.
Publicado: (2022)

Psoriasis in the U.S. Medicare population: prevalence, treatment, and factors associated with biologic use
por: Takeshita, Junko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_go2e6bkqravmhggcf8tph62pkj